Form 4: Iradimed Corp Executive Jeff Chiprin Receives Stock Awards

Chief Commercial Officer of Iradimed Corp, Jeff Chiprin, was granted restricted stock units and performance-based restricted stock units on December 11, 2024.

Summary

• Jeff Chiprin, Chief Commercial Officer of Iradimed Corp, received 2,990 restricted stock units (RSUs) and 2,989 performance-based restricted stock units (PRSUs) on December 11, 2024.
• The RSUs will vest in three equal annual installments starting December 11, 2025.
• The PRSUs vest over a three-year performance period from December 12, 2024, through December 11, 2027, based on the company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.
• Both RSUs and PRSUs convert into common stock on a one-for-one basis upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The stock awards align the executive's interests with the company's long-term performance.
• The vesting schedule of the RSUs encourages continued service by the executive.
• The performance-based vesting of the PRSUs incentivizes the executive to drive shareholder value.

Risks

• The performance-based vesting of the PRSUs is subject to market conditions and the company's performance relative to the NASDAQ US Small Cap Medical Equipment index.
• The value of the stock awards is subject to the volatility of the company's stock price.

Future Outlook

The vesting of the stock awards is contingent on continued service and performance, aligning executive interests with long-term company success.

Industry Context

Stock-based compensation is a common practice in the medical device industry to attract and retain key executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice for executive compensation in the medical device industry.
• Companies like Stryker, Medtronic, and Boston Scientific also use stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and performance metrics used by Iradimed are typical for the industry.

Stakeholder Impact

• Shareholders may view the stock awards positively as they align executive interests with long-term company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock awards, restricted stock units, performance-based restricted stock units, equity compensation, executive compensation, vesting, Iradimed Corp, Jeff Chiprin